A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease

Background & Aims: The shortage of liver grafts continues to worsen. Because the expanded use of small-for-size grafts (SFSGs) would substantially alleviate this shortage, we aimed to analyse the available knowledge on auxiliary liver transplantation (ALT) with SFSGs in patients with chronic...

Full description

Bibliographic Details
Main Authors: Daniel Azoulay, Cyrille Feray, Chetana Lim, Chady Salloum, Maria Conticchio, Daniel Cherqui, Antonio Sa Cunha, René Adam, Eric Vibert, Didier Samuel, Marc Antoine Allard, Nicolas Golse
Format: Article
Language:English
Published: Elsevier 2022-04-01
Series:JHEP Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2589555922000192
_version_ 1828859076376788992
author Daniel Azoulay
Cyrille Feray
Chetana Lim
Chady Salloum
Maria Conticchio
Daniel Cherqui
Antonio Sa Cunha
René Adam
Eric Vibert
Didier Samuel
Marc Antoine Allard
Nicolas Golse
author_facet Daniel Azoulay
Cyrille Feray
Chetana Lim
Chady Salloum
Maria Conticchio
Daniel Cherqui
Antonio Sa Cunha
René Adam
Eric Vibert
Didier Samuel
Marc Antoine Allard
Nicolas Golse
author_sort Daniel Azoulay
collection DOAJ
description Background & Aims: The shortage of liver grafts continues to worsen. Because the expanded use of small-for-size grafts (SFSGs) would substantially alleviate this shortage, we aimed to analyse the available knowledge on auxiliary liver transplantation (ALT) with SFSGs in patients with chronic liver disease (CLD) to identify opportunities to develop ALT with SFSGs in patients with CLD. Methods: This is a systematic review on ALT using SFSGs in patients with CLD. The review was completed by updates obtained from the authors of the retained reports. Results: Heterotopic ALT was performed in 26 cases between 1980 and 2017, none for SFGS stricto sensu, and auxiliary partial orthotopic liver transplantation (APOLT) in 27 cases (from 1999 to 2021), all for SFSG. In APOLT cases, partial native liver resection was performed in most of cases, whereas the second-stage remnant native liver hepatectomy was performed in 9 cases only. The median graft-to-body weight ratio was 0.55, requiring perioperative or intraoperative portal modulation in 16 cases. At least 1 complication occurred in 24 patients following the transplant procedure (morbidity rate, 89%). Four patients (4/27, 15%) died after the APOLT procedure. At the long term, 19 (70%) patients were alive and well at 13 months to 24 years (median, 4.5 years) including 18 with the APOLT graft in place and 1 following retransplantation. Conclusions: Despite high postoperative morbidity, and highly reported technical variability, the APOLT technique is a promising technique to use SFSGs in patients with CLD, achieving satisfactory long-term results. The results need to be confirmed on a larger scale, and a standardised technique could lead to even better results. Lay summary: At the cost of a high postoperative morbidity, the long-term results of APOLT for small-for-size grafts are good. Standardisation of the procedure and of portal modulation remain needed.
first_indexed 2024-12-13T02:10:44Z
format Article
id doaj.art-ac7044efc8984e119811a854afea16c7
institution Directory Open Access Journal
issn 2589-5559
language English
last_indexed 2024-12-13T02:10:44Z
publishDate 2022-04-01
publisher Elsevier
record_format Article
series JHEP Reports
spelling doaj.art-ac7044efc8984e119811a854afea16c72022-12-22T00:03:02ZengElsevierJHEP Reports2589-55592022-04-0144100447A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver diseaseDaniel Azoulay0Cyrille Feray1Chetana Lim2Chady Salloum3Maria Conticchio4Daniel Cherqui5Antonio Sa Cunha6René Adam7Eric Vibert8Didier Samuel9Marc Antoine Allard10Nicolas Golse11Department of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, France; Corresponding author. Address: Centre Hépato-Biliaire, Hôpital Paul Brousse, 94000, Villejuif, France. Tel.: +33 1 45 59 30 49, fax: +33 1 45 59 38 57.INSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, France; Department of Hepatology, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, FranceDepartment of Surgery, Pitié-Salpêtrière Hospital, Université Paris-Descartes, Paris, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Unité 985, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, FranceINSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, France; Department of Hepatology, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Unité 985, Villejuif, FranceDepartment of Surgery, Paul-Brousse Hospital, Assistance Publique Hôpitaux de Paris, Centre Hépato-Biliaire, Villejuif, France; INSERM, Université Paris-Saclay, UMRS 1193, Physiopathogénèse et traitement des maladies du Foie, FHU Hepatinov, Villejuif, FranceBackground & Aims: The shortage of liver grafts continues to worsen. Because the expanded use of small-for-size grafts (SFSGs) would substantially alleviate this shortage, we aimed to analyse the available knowledge on auxiliary liver transplantation (ALT) with SFSGs in patients with chronic liver disease (CLD) to identify opportunities to develop ALT with SFSGs in patients with CLD. Methods: This is a systematic review on ALT using SFSGs in patients with CLD. The review was completed by updates obtained from the authors of the retained reports. Results: Heterotopic ALT was performed in 26 cases between 1980 and 2017, none for SFGS stricto sensu, and auxiliary partial orthotopic liver transplantation (APOLT) in 27 cases (from 1999 to 2021), all for SFSG. In APOLT cases, partial native liver resection was performed in most of cases, whereas the second-stage remnant native liver hepatectomy was performed in 9 cases only. The median graft-to-body weight ratio was 0.55, requiring perioperative or intraoperative portal modulation in 16 cases. At least 1 complication occurred in 24 patients following the transplant procedure (morbidity rate, 89%). Four patients (4/27, 15%) died after the APOLT procedure. At the long term, 19 (70%) patients were alive and well at 13 months to 24 years (median, 4.5 years) including 18 with the APOLT graft in place and 1 following retransplantation. Conclusions: Despite high postoperative morbidity, and highly reported technical variability, the APOLT technique is a promising technique to use SFSGs in patients with CLD, achieving satisfactory long-term results. The results need to be confirmed on a larger scale, and a standardised technique could lead to even better results. Lay summary: At the cost of a high postoperative morbidity, the long-term results of APOLT for small-for-size grafts are good. Standardisation of the procedure and of portal modulation remain needed.http://www.sciencedirect.com/science/article/pii/S2589555922000192Organ shortageChronic liver diseaseLiver transplantationSmall-for-size graftSmall-for-size syndromeAuxiliary liver transplantation
spellingShingle Daniel Azoulay
Cyrille Feray
Chetana Lim
Chady Salloum
Maria Conticchio
Daniel Cherqui
Antonio Sa Cunha
René Adam
Eric Vibert
Didier Samuel
Marc Antoine Allard
Nicolas Golse
A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
JHEP Reports
Organ shortage
Chronic liver disease
Liver transplantation
Small-for-size graft
Small-for-size syndrome
Auxiliary liver transplantation
title A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
title_full A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
title_fullStr A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
title_full_unstemmed A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
title_short A systematic review of auxiliary liver transplantation of small-for-size grafts in patients with chronic liver disease
title_sort systematic review of auxiliary liver transplantation of small for size grafts in patients with chronic liver disease
topic Organ shortage
Chronic liver disease
Liver transplantation
Small-for-size graft
Small-for-size syndrome
Auxiliary liver transplantation
url http://www.sciencedirect.com/science/article/pii/S2589555922000192
work_keys_str_mv AT danielazoulay asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT cyrilleferay asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT chetanalim asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT chadysalloum asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT mariaconticchio asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT danielcherqui asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT antoniosacunha asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT reneadam asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT ericvibert asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT didiersamuel asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT marcantoineallard asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT nicolasgolse asystematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT danielazoulay systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT cyrilleferay systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT chetanalim systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT chadysalloum systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT mariaconticchio systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT danielcherqui systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT antoniosacunha systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT reneadam systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT ericvibert systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT didiersamuel systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT marcantoineallard systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease
AT nicolasgolse systematicreviewofauxiliarylivertransplantationofsmallforsizegraftsinpatientswithchronicliverdisease